ArticleEuropean journal of medicinal chemistry2017

Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation.

Madia Letizia Stama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.